On ECHEMI
Home > Drugs > Colorectal cancer
Colorectal cancer
Colorectal cancer refers to malignant lesions of the colorectal mucosal epithelium caused by a variety of carcinogenic factors such as the environment or genetics. It has a poor prognosis and a high mortality rate. It is one of the common malignant tumors in my country. Among them, malignant tumors arising from the mucosal epithelium are collectively referred to as colorectal cancer, which is the most common malignant tumor of the gastrointestinal tract. Those originating from mesenchymal tissue are called sarcomas, which account for about 1% of colorectal malignant lesions. The average 5-year survival rate after surgical resection can reach 40% to 60%. Early detection, early diagnosis, early treatment and standardized surgical treatment are still the key to improving the efficacy of colorectal cancer.
  • Site of disease:

    intestinal
  • Infectious :

    Not contagious
  • Frequent population:

    Middle-aged and elderly people
  • Related symptoms:

    Abdominal mass abdominal pain blood in stool stool becomes thinner and shaped like a pencil defecation disorder
  • Concurrent disease:

Related Drugs
Thymopentin injection
Indication: For chronic hepatitis B patients over 18 years old. Because the thymus begins to atrophy after 18 years old, the cellular immune function is reduced. 2 Various primary or secondary T cell deficiency diseases. 3 Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). 4 Various diseases with low cellular immune function. 5 Adjuvant treatment of tumors.
Manufacturer:

Hainan Zhonghe Pharmaceutical Co., Ltd.

Paclitaxel
Indication: It is suitable for ovarian cancer and breast cancer, and also has certain effects on lung cancer, colorectal cancer, melanoma, head and neck cancer, lymphoma, and brain tumors.
Manufacturer:

Gulin Huiang Biochemistry Pharmaceutical Co., Ltd.

Paclitaxel
Indication: It is suitable for ovarian cancer and breast cancer, and also has certain effects on lung cancer, colorectal cancer, melanoma, head and neck cancer, lymphoma, and brain tumors.
Manufacturer:

Haikou Pharmaceutical Factory Co., Ltd.

Paclitaxel
Indication: It is suitable for ovarian cancer and breast cancer, and also has certain effects on lung cancer, colorectal cancer, melanoma, head and neck cancer, lymphoma, and brain tumors.
Paclitaxel
Indication: It is suitable for ovarian cancer and breast cancer, and also has certain effects on lung cancer, colorectal cancer, melanoma, head and neck cancer, lymphoma, and brain tumors.
Paclitaxel
Indication: It is suitable for ovarian cancer and breast cancer, and also has certain effects on lung cancer, colorectal cancer, melanoma, head and neck cancer, lymphoma, and brain tumors.
Bozhi Glycopeptide Injection
Indication: It is used for progressive muscular dystrophy, myotonia atrophica, vertigo caused by vestibular dysfunction, hypertension, autonomic dysfunction, epilepsy, insomnia, etc. It can also be used as an auxiliary treatment for tumors and hepatitis.
Manufacturer:

Beijing Science Sun Pharmaceutical Co., Ltd.

Irinotecan Hydrochloride Injection
Indication: This product is suitable for the treatment of patients with advanced colorectal cancer: combined with 5-fluorouracil and folinic acid to treat patients with advanced colorectal cancer who have not received chemotherapy before; as a single drug, to treat patients who have failed chemotherapy containing 5-fluorouracil.
Manufacturer:

Qilu Pharmaceutical (Hainan) Co., Ltd.

Paclitaxel
Indication: It is suitable for ovarian cancer and breast cancer, and also has certain effects on lung cancer, colorectal cancer, melanoma, head and neck cancer, lymphoma, and brain tumors.
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.